Lodosyn

Active Ingredient(s): Carbidopa
FDA Approved: April 25, 1977
Pharm Company: BRISTOL MYERS SQUIBB
Category: Parkinsons

Welcome to the Lodosyn information hub. Scroll down to read supplemental details and discuss this drug.

Lodosyn Overview

Carbidopa (Lodosyn) is a drug given to people with Parkinson's disease in order to inhibit peripheral metabolism of levodopa. This property is significant in that it allows a greater proportion of peripheral levodopa to cross the blood brain barrier for central nervous system effect. Contents 1 Pharmacology 2 Uses 3 References 4 External links Pharmacology Carbidopa inhibits aromatic-L-amino-acid decarboxylase (DOPA Decarboxylase or DDC),[1] an enzyme important in the biosynthe...

Read more Lodosyn Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: http://en.wikipedia.org/wiki/Carbidopa

Recent Lodosyn Forums:

Possible Dosages for this and Related Drugs:

Other drugs which contain Carbidopa or a similar ingredient: (10 results)